The ASX fell 0.09pc in trade today, but positive employment data lifted the likelihood of an interest rate cut in July.

QMines will expand its precious metals position in central Queensland through the acquisition of Mount Mackenzie gold and ...

A medtech that raised $6m is tapping investors again to expand its hyper-realistic human models that allow cost-effective ...

In this episode, host Tylah Tully unpacks EZZ Life Science (ASX:EZZ) latest news. They have o fficially entered one of the world’s largest markets for health supplements, with the launch of its new ...

In a busy reporting day for biotechs, Orthocell reports promising results of a follow-up study of its nerve repair device Remplir.

The ASX moves further into the afternoon in a flattish state. Iron ore has dipped, the Fed has flagged inflation and WiseTech has slid.

A comfortable retirement is more within reach for younger workers, and cost of essentials is easing for seniors. Here are the latest figures.

ASX slips 0.16pc as tech and materials sectors lag. Amplia Therapeutics reports a second complete response in its pancreatic cancer trial.

These ASX mining juniors could be in the cross-hairs as 2025's next takeover targets according to our expert panel.

Ausgold is on the home straight to deliver the key definitive feasibility study for its Katanning gold project in WA’s Great ...

Military metals tungsten, tin, beryllium, rare earths and antimony are on investors' radars as war rages in the Middle East.